Barbara Depreter

Conference Paper
C3
open access

Deciphering the non-coding landscape of pediatric acute myeloid leukemia

Jolien Vanhooren (UGent) , Laurens Van Camp (UGent) , Barbara Depreter, Martijn de Jong (UGent) , Anne Uyttebroeck, An Van Damme, Laurence Dedeken, Marie-Françoise Dresse, Jutte van der Werff ten Bosch, Mattias Hofmans (UGent) , et al.

(2022) BVK (Belgische Vereniging voor Kindergeneeskunde) Congress 2022, Abstracts.

Add to list

Journal Article
A1
open access

TARP as antigen in cancer immunotherapy

Jolien Vanhooren (UGent) , Charlotte Derpoorter (UGent) , Barbara Depreter, Larissa Deneweth (UGent) , Jan Philippé (UGent) , Barbara De Moerloose (UGent) and Tim Lammens (UGent)

(2021) CANCER IMMUNOLOGY IMMUNOTHERAPY. 70. p.3061-3068

Add to list

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2021) PEDIATRIC RESEARCH. 89(7). p.1695-1705

Add to list

Journal Article
A2
open access

Leukaemic stem cells in AML : where are we now? An update on recent findings and detection

Barbara Depreter, Barbara De Moerloose (UGent) , Jan Philippé (UGent) and Tim Lammens (UGent)

(2020) BELGIAN JOURNAL OF HEMATOLOGY. 11(6). p.246-252

Add to list

PhD Thesis
open access

Exploring the molecular and phenotypical heterogeneity between patients with pediatric acute myeloid leukemia

Barbara Depreter

(2020)

Add to list

Journal Article
A1
open access

Clinical significance of TARP expression in pediatric acute myeloid leukemia

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Barbara Denys, Laurence Dedeken, Marie-Françoise Dresse, Jutte Van Der Werff Ten Bosch, Mattias Hofmans (UGent) , et al.

(2020) HEMASPHERE. 4(2).

Add to list

Journal Article
A1
open access

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , Magnus Essand, Barbara De Moerloose (UGent) , Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2020) HAEMATOLOGICA. 105(5). p.1306-1316

Add to list

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia : proof of concept study

Mattias Hofmans (UGent) , Barbara Depreter, Tim Lammens (UGent) , Helene Cave, Christian Flotho, Henrik Hasle, Valerie de Haas, Charlotte M. Niemeyer, Jan Stary, Pieter Van Vlierberghe (UGent) , et al.

(2019) BLOOD. 134(Supplement 1). p.1701-1701

Add to list

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter, Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte Van der Werff Ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) BLOOD. 134(S1). p.1457-1457

Add to list

Conference Paper
C3
open access

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter, Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte van der Werff ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) American Society of Hematology, 61st Annual meeting, Abstracts.

Add to list

Conference Paper
C3
open access

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , M Essand, Barbara De Moerloose (UGent) , M Themeli, J Cloos, D Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2019) HEMASPHERE. 3(suppl. 1). p.54-54

Add to list

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients

Diana Hanekamp, Barbara Denys (UGent) , Gertjan JL Kaspers, Jeroen G te Marvelde, Gerrit Jan Schuurhuis, Valerie De Haas, Barbara De Moerloose (UGent) , Eveline S de Bont, C Michel Zwaan, Anja de Jong, et al.

(2018) BRITISH JOURNAL OF HAEMATOLOGY. 183(3). p.512-516

Add to list

Cancer-related mRNA expression analysis using a novel flow cytometry-based assay

Barbara Depreter, Jan Philippé (UGent) , MAGALI MEUL (UGent) , Barbara Denys (UGent) , Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) and Tim Lammens (UGent)

(2018) CYTOMETRY PART B-CLINICAL CYTOMETRY. 94(4). p.565-575

Add to list

Dilute Russell's viper venom time reagents in lupus anticoagulant testing : a well-considered choice

Barbara Depreter and Katrien Devreese (UGent)

(2017) CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 55(1). p.91-101

Add to list

Differences between dilute Russell's viper venom time reagents in lupus anticoagulant testing

Barbara Depreter and Katrien Devreese (UGent)

(2016) Thrombosis and Haemostasis, European congress, Abstracts.

Academic Bibliography

Barbara Depreter

Deciphering the non-coding landscape of pediatric acute myeloid leukemia

TARP as antigen in cancer immunotherapy

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Leukaemic stem cells in AML : where are we now? An update on recent findings and detection

Exploring the molecular and phenotypical heterogeneity between patients with pediatric acute myeloid leukemia

Clinical significance of TARP expression in pediatric acute myeloid leukemia

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia : proof of concept study

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients

Cancer-related mRNA expression analysis using a novel flow cytometry-based assay

Dilute Russell's viper venom time reagents in lupus anticoagulant testing : a well-considered choice

Differences between dilute Russell's viper venom time reagents in lupus anticoagulant testing

Contents

Support

Contact